SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Susannah Maxwell, Ian James, Jan E. Dickinson, Peter O'Leary, First trimester screening cut-offs for noninvasive prenatal testing as a contingent screen: Balancing detection and screen-positive rates for trisomy 21, Australian and New Zealand Journal of Obstetrics and Gynaecology, 2016, 56, 1
  2. 2
    Melissa L. Russo, Karin J. Blakemore, A historical and practical review of first trimester aneuploidy screening, Seminars in Fetal and Neonatal Medicine, 2014, 19, 3, 183

    CrossRef

  3. 3
    Amy Metcalfe, Catriona Hippman, Melanie Pastuck, Jo-Ann Johnson, Beyond Trisomy 21: Additional Chromosomal Anomalies Detected through Routine Aneuploidy Screening, Journal of Clinical Medicine, 2014, 3, 2, 388

    CrossRef

  4. 4
    Camilla H B Jespersen, Kirstine R Vestergaard, Morten Schou, Børge Teisner, Jens P Goetze, Kasper Iversen, Pregnancy-associated plasma protein-A and the vulnerable plaque, Biomarkers in Medicine, 2014, 8, 8, 1033

    CrossRef

  5. 5
    Sevsen Kulaksizoglu, Mustafa Kulaksizoglu, Ayse Gul Kebapcilar, Ayse Nur Torun, Emel Ozcimen, Suna Turkoglu, Can first-trimester screening program detect women at high risk for gestational diabetes mellitus?, Gynecological Endocrinology, 2013, 29, 2, 137

    CrossRef

  6. 6
    Amy Metcalfe, Gillian Currie, Jo-Ann Johnson, Francois Bernier, Lisa M. Lix, Andrew W. Lyon, Suzanne C. Tough, Impact of observed versus hypothesized service utilization on the incremental cost of first trimester screening and prenatal diagnosis for trisomy 21 in a Canadian province, Prenatal Diagnosis, 2013, 33, 5
  7. 7
    A.-S. Weingertner, N.-T. Trieu, M. Kohler, B. Viville, G. Levy, Y. Montaya, R. Kutnahorsky, I. Tissier, A. Kohler, M. Tanghe, C. Mager, E. Benassi, M. Cancelier, M. Neuman, N. Bouffet, M.C. Hunsinger, F. Hornecker, B. Langer, I. Nisand, R. Favre, Dépistage combiné de la trisomie 21 au premier trimestre : à propos de cinq ans d’expérience prospective multicentrique, La Revue Sage-Femme, 2011, 10, 2, 72

    CrossRef

  8. 8
    David Krantz, Terrence Hallahan, Rachel Ravens, Kuanglin He, Howard Cuckle, John Sherwin, Jonathan Carmichael, First trimester Down syndrome screening with dried blood spots using a dual analyte free beta hCG and PAPP-A immunofluorometric assay, Prenatal Diagnosis, 2011, 31, 9
  9. 9
    Nicholas J. Cowans, Anastasia Stamatopoulou, Paivi Liitti, Mikko Suonpaa, Kevin Spencer, The stability of free-β human chorionic gonadotrophin and pregnancy-associated plasma protein-A in first trimester dried blood spots, Prenatal Diagnosis, 2011, 31, 3
  10. 10
    Nanhornguè Kimta, Ville Yves, High Risk Pregnancy, 2011,

    CrossRef

  11. 11
    A.-S. Weingertner, N.-T. Trieu, M. Kohler, B. Viville, G. Levy, Y. Montaya, R. Kutnahorsky, I. Tissier, A. Kohler, M. Tanghe, C. Mager, E. Benassi, M. Cancelier, M. Neuman, N. Bouffet, M.C. Hunsinger, F. Hornecker, B. Langer, I. Nisand, R. Favre, Dépistage combiné de la trisomie 21 au premier trimestre : à propos de cinq ans d’expérience prospective multicentrique, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, 2010, 39, 5, 353

    CrossRef

  12. 12
    Michael Schaelike, Maria Kossakiewicz, Andreas Kossakiewicz, Ralf L. Schild, Examination of a first-trimester Down syndrome screening concept on a mix of 11,107 high- and low-risk patients at a private center for prenatal medicine in Germany, European Journal of Obstetrics & Gynecology and Reproductive Biology, 2009, 144, 2, 140

    CrossRef

  13. 13
    Elena Cortés Cros, Mónica Álvarez Sánchez, Leonor Valle Morales, Ramón Giné Benaiges, Anselmo García Fernández, José Ángel García Hernández, Impacto de la implementación del test combinado para el cribado de trisomía 21 en Gran Canaria. Experiencia de los tres primeros años, Progresos de Obstetricia y Ginecología, 2009, 52, 7, 371

    CrossRef

  14. 14
    R. MacRae, D. Ojutiku, J. Duke-MacRae, F. Usifo, M. Ekong, Evaluating nuchal translucency scans performed for trisomy screening in a district general hospital between July 1998 and January 2004, Journal of Obstetrics & Gynaecology, 2008, 28, 7, 683

    CrossRef

  15. 15
    K. Offerdal, H.-G. K. Blaas, S. H. Eik-Nes, Prenatal detection of trisomy 21 by second-trimester ultrasound examination and maternal age in a non-selected population of 49 314 births in Norway, Ultrasound in Obstetrics & Gynecology, 2008, 32, 4
  16. 16
    F M. Ndumbe, O Navti, V N. Chilaka, J C. Konje, Prenatal Diagnosis in the First Trimester of Pregnancy, Obstetrical & Gynecological Survey, 2008, 63, 5, 317

    CrossRef

  17. 17
    Glenn E Palomaki, Louis M Neveux, George J Knight, James E Haddow, Joellen Lee, Estimating first-trimester combined screening performance for Down syndrome in dried blood spots versus fresh sera, Genetics in Medicine, 2007, 9, 7, 458

    CrossRef

  18. 18
    Mohammed-Salleh M. Ardawi, Hasan A. Nasrat, Abdulrahim A. Rouzi, Mohammed H. Qari, Mohammed H. Al-Qahtani, Adel M. Abuzenadah, Maternal serum free-β-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10–13+6 weeks in relation to co-variables in pregnant Saudi women, Prenatal Diagnosis, 2007, 27, 4
  19. 19
    Mark I. Evans, David A. Krantz, Terrence W. Hallahan, Robert S. Galen, Meta-analysis of first trimester Down syndrome screening studies: free β-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocol, American Journal of Obstetrics and Gynecology, 2007, 196, 3, 198

    CrossRef

  20. 20
    Aaron B. Caughey, Thomas J. Musci, Jenny Belluomini, Denise Main, Carl Otto, James Goldberg, Nuchal translucency screening: how do women actually utilize the results?, Prenatal Diagnosis, 2007, 27, 2
  21. 21
    MSM Ardawi, HA Nasrat, AA Rouzi, MH Qari, MH Al-Qahtani, AM Abuzenadah, The effect of cigarette or sheesha smoking on first-trimester markers of Down syndrome, BJOG: An International Journal of Obstetrics & Gynaecology, 2007, 114, 11
  22. 22
    Glenn E. Palomaki, Geralyn M. Lambert-Messerlian, Jacob A. Canick, 2007,

    CrossRef

  23. 23
    David A. Nyberg, Jon Hyett, Jo-Ann Johnson, Vivienne Souter, First-Trimester Screening, Radiologic Clinics of North America, 2006, 44, 6, 837

    CrossRef

  24. 24
    David A. Nyberg, Jon Hyett, Jo-Ann Johnson, Vivienne Souter, First-Trimester Screening, Ultrasound Clinics, 2006, 1, 2, 231

    CrossRef

  25. 25
    David Krantz, Terrence Hallahan, Stephanie Ishack, V. James Macri, James N. Macri, First-trimester maternal dried blood Down syndrome screening marker levels in early pregnancy loss, Prenatal Diagnosis, 2006, 26, 12
  26. 26
    Kirsten Marie Schiøtt, Michael Christiansen, Olav Bjørn Petersen, Tina Lind Sørensen, Niels Uldbjerg, The “Consecutive Combined Test”—using Double test from week 8 + 0 and Nuchal Translucency Scan, for first trimester screening for Down Syndrome, Prenatal Diagnosis, 2006, 26, 12
  27. 27
    D Krantz, T Hallahan, J Macri, Textbook of Perinatal Medicine, Second Edition, 2006,

    CrossRef

  28. 28
    A. Borrell, E. Casals, A. Fortuny, A. Goncé, I. Mercadé, A. Serés, C. González, V. Cararach, J.A. Vanrell, Cribado de trisomía 21 en el primer trimestre mediante test combinado de bioquímica y ecografía. Estudio prospectivo de intervención, Progresos de Obstetricia y Ginecología, 2005, 48, 5, 223

    CrossRef

  29. 29
    P. Rozenberg, Dépistage de la trisomie 21 par échographie, Immuno-analyse & Biologie Spécialisée, 2005, 20, 2, 103

    CrossRef

  30. 30
    P. Rozenberg, Dépistage de la trisomie 21 par échographie, Gynécologie Obstétrique & Fertilité, 2005, 33, 7-8, 526

    CrossRef

  31. 31
    Lawrence D. Platt, First-Trimester Risk Assessment: Twin Gestations, Seminars in Perinatology, 2005, 29, 4, 258

    CrossRef

  32. 32
    David A. Krantz, Terrence W. Hallahan, V. James Macri, James N. Macri, Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program, Prenatal Diagnosis, 2005, 25, 8
  33. 33
    Wilfried J. A. Gyselaers, Annie J. Vereecken, Erik J. H. Van Herck, Dany P. L. Straetmans, Eric T. M. de Jonge, Willem U. A. M. Ombelet, Jan G. Nijhuis, Population screening for fetal trisomy 21: easy access to screening should be balanced against a uniform ultrasound protocol, Prenatal Diagnosis, 2005, 25, 11
  34. 34
    Marta C. Wille, Beth Weitz, Peggy Kerper, Stephanie Frazier, Advances in Preconception Genetic Counseling, The Journal of Perinatal & Neonatal Nursing, 2004, 18, 1, 28

    CrossRef

  35. 35
    Joseph R Biggio, T.Christopher Morris, John Owen, Jeffery S.A Stringer, An outcomes analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years, American Journal of Obstetrics and Gynecology, 2004, 190, 3, 721

    CrossRef

  36. 36
    C. Bach, S. Torrent, D. Cabrero, J. Sabrià, Cribado bioquímico-ecográfico de las aneuploidías en el primer trimestre. Metodología y resultados, Progresos de Obstetricia y Ginecología, 2004, 47, 1, 5

    CrossRef

  37. 37
    Ray O. Bahado-Singh, Sang-Joon Choi, Chih Chien Cheng, First- and midtrimester Down syndrome screening and detection, Clinics in Perinatology, 2004, 31, 4, 677

    CrossRef

  38. 38
    E. J. Stenhouse, J. A. Crossley, D. A. Aitken, K. Brogan, A. D. Cameron, J. M. Connor, First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice, Prenatal Diagnosis, 2004, 24, 10
  39. 39
    M Christiansen, SO Larsen, C Oxvig, Q-P Qin, JM Wagner, MT Overgaard, GJ Gleich, L Sottrup-Jensen, B Nørgaard-Pedersen, Screening for Down's syndrome in early and late first and second trimester using six maternal serum markers, Clinical Genetics, 2004, 65, 1
  40. 40
    Deborah A Driscoll, Second trimester maternal serum screening for fetal open neural tube defects and aneuploidy, Genetics in Medicine, 2004, 6, 6, 540

    CrossRef

  41. 41
    Wilfried J.A. Gyselaers, Annie J. Vereecken, Erik van Herck, Dany P.L. Straetmans, Eric T.M. de Jonge, Willem U.A.M. Ombelet, Jan G. Nijhuis, Single-Step Maternal Serum Screening for Trisomy 21 in the Era of Combined or Integrated Screening, Gynecologic and Obstetric Investigation, 2004, 58, 4, 221

    CrossRef

  42. 42
    Jennifer A. Bubb, Anne L. Matthews, What's new in prenatal screening and diagnosis?, Primary Care: Clinics in Office Practice, 2004, 31, 3, 561

    CrossRef

  43. 43
    S. T. Chasen, G. Sharma, R. B. Kalish, F. A. Chervenak, First-trimester screening for aneuploidy with fetal nuchal translucency in a United States population, Ultrasound in Obstetrics & Gynecology, 2003, 22, 2
  44. 44
    F. Orlandi, C. M. Bilardo, M. Campogrande, D. Krantz, T. Hallahan, C. Rossi, E. Viora, Measurement of nasal bone length at 11–14 weeks of pregnancy and its potential role in Down syndrome risk assessment, Ultrasound in Obstetrics & Gynecology, 2003, 22, 1
  45. 45
    Marko Niemimaa, Seppo Heinonen, Maija Seppälä, Markku Ryynänen, The influence of smoking on the pregnancy-associated plasma protein A, free β human chorionic gonadotrophin and nuchal translucency, BJOG: An International Journal of Obstetrics & Gynaecology, 2003, 110, 7
  46. 46
    Francesco Orlandi, Cinzia Rossi, A. Allegra, David Krantz, Terrence Hallahan, Emanuela Orlandi, James Macri, First trimester screening with free β-hCG, PAPP-A and nuchal translucency in pregnancies conceived with assisted reproduction, Prenatal Diagnosis, 2002, 22, 8
  47. 47
    Aaron B. Caughey, Miriam Kuppermann, Mary E. Norton, A.Eugene Washington, Nuchal translucency and first trimester biochemical markers for down syndrome screening: A cost-effectiveness analysis, American Journal of Obstetrics and Gynecology, 2002, 187, 5, 1239

    CrossRef

  48. 48
    K. Schuchter, E. Hafner, G. Stangl, M. Metzenbauer, D. Höfinger, K. Philipp, The first trimester ‘combined test’ for the detection of Down syndrome pregnancies in 4939 unselected pregnancies, Prenatal Diagnosis, 2002, 22, 3
  49. 49
    Pierangela De Biasio, Silvana Canini, Federico Prefumo, Pier Luigi Venturini, Trisomy 18 in a fetus with normal NT and abnormal maternal serum biochemistry, Prenatal Diagnosis, 2002, 22, 6
  50. 50
    JE Brennand, AD Cameron, Current methods of screening for Down syndrome, The Obstetrician & Gynaecologist, 2001, 3, 4
    Direct Link:
  51. 51
    A. Herman, Z. Weinraub, E. Dreazen, S. Arieli, S. Rozansky, I. Bukovsky, R. Maymon, Combined first trimester nuchal translucency and second trimester biochemical screening tests among normal pregnancies, Prenatal Diagnosis, 2000, 20, 10
  52. 52
    T. Hallahan, D. Krantz, F. Orlandi, C. Rossi, P. Curcio, S. Macri, J. Larsen, P. Buchanan, J. Macri, First trimester biochemical screening for Down syndrome: free beta hCG versus intact hCG, Prenatal Diagnosis, 2000, 20, 10
  53. 53
    Fergal D. Malone, Richard L. Berkowitz, Jacob A. Canick, Mary E. D’Alton, First-trimester screening for aneuploidy: Research or standard of care?, American Journal of Obstetrics and Gynecology, 2000, 182, 3, 490

    CrossRef

  54. 54
    Jill Mauldin, Prenatal diagnosis and fetal therapy-what lies in future?, The Indian Journal of Pediatrics, 2000, 67, 12, 899

    CrossRef

  55. 55
    David A. Nyberg, Vivienne L. Souter, SONOGRAPHIC MARKERS OF FETAL ANEUPLOIDY, Clinics in Perinatology, 2000, 27, 4, 761

    CrossRef

  56. 56
    Howard Cuckle, Indera Sehmi, Calculating correct Down's syndrome risks, BJOG: An International Journal of Obstetrics & Gynaecology, 1999, 106, 4
  57. 57
    Theresa L. Stewart, Fergal D. Malone, First trimester screening for aneuploidy: Nuchal translucency sonography, Seminars in Perinatology, 1999, 23, 5, 369

    CrossRef

  58. 58
    Jacob A. Canick, Leonard H. Kellner, First trimester screening for aneuploidy: Serum biochemical markers, Seminars in Perinatology, 1999, 23, 5, 359

    CrossRef

  59. 59
    Jon Hyett, Basky Thilaganathan, First trimester screening for fetal abnormalities, Current Opinion in Obstetrics and Gynecology, 1999, 11, 6, 563

    CrossRef

  60. 60
    S Kate Alldred, Yemisi Takwoingi, Boliang Guo, Mary Pennant, Jonathan J Deeks, James P Neilson, Zarko Alfirevic, First trimester serum tests for Down's syndrome screening, The Cochrane Library,